BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Filippatos TD, Alexakis K, Mavrikaki V, Mikhailidis DP. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis. Dig Dis Sci 2021. [PMID: 33469809 DOI: 10.1007/s10620-021-06824-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Park H, Yoon EL, Kim M, Cho S, Kim JH, Jun DW, Nah EH. Selecting the Target Population for Screening of Hepatic Fibrosis in Primary Care Centers in Korea. J Clin Med 2022;11:1474. [PMID: 35329799 DOI: 10.3390/jcm11061474] [Reference Citation Analysis]
2 Filippatos TD. Non-Alcoholic Fatty Pancreas Disease: A Diagnosis of Increasing Importance. Angiology 2021;:33197211053902. [PMID: 34747669 DOI: 10.1177/00033197211053902] [Reference Citation Analysis]
3 Ma R, Zhan Y, Zhang Y, Wu L, Wang X, Guo M. Schisandrin B ameliorates non-alcoholic liver disease through anti-inflammation activation in diabetic mice. Drug Dev Res 2021. [PMID: 34927282 DOI: 10.1002/ddr.21905] [Reference Citation Analysis]
4 Chang M. Fatty Pancreas-Centered Metabolic Basis of Pancreatic Adenocarcinoma: From Obesity, Diabetes and Pancreatitis to Oncogenesis. Biomedicines 2022;10:692. [DOI: 10.3390/biomedicines10030692] [Reference Citation Analysis]
5 Kosmalski M, Ziółkowska S, Czarny P, Szemraj J, Pietras T. The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. J Clin Med 2022;11:1375. [PMID: 35268466 DOI: 10.3390/jcm11051375] [Reference Citation Analysis]
6 Muzurović E, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism 2021;119:154770. [PMID: 33864798 DOI: 10.1016/j.metabol.2021.154770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Schepis T, De Lucia SS, Nista EC, Manilla V, Pignataro G, Ojetti V, Piccioni A, Gasbarrini A, Franceschi F, Candelli M. Microbiota in Pancreatic Diseases: A Review of the Literature. J Clin Med 2021;10:5920. [PMID: 34945216 DOI: 10.3390/jcm10245920] [Reference Citation Analysis]
8 Hong C, Yan Y, Su L, Chen D, Zhang C. Development of a risk-stratification scoring system for predicting risk of breast cancer based on non-alcoholic fatty liver disease, non-alcoholic fatty pancreas disease, and uric acid. Open Medicine 2022;17:619-25. [DOI: 10.1515/med-2022-0462] [Reference Citation Analysis]